Julia Lainster

A pioneering development in geriatric medicine from the University of Arizona's Gutruf Lab has unveiled an advanced wearable device that employs artificial intelligence to proactively identify the earliest indicators of frailty in older adults. This groundbreaking technology represents a

In a region where a colorectal cancer diagnosis is often synonymous with a grim prognosis due to late detection, a groundbreaking pilot program in Osun State, Nigeria, has ignited new hope. With roughly 80% of patients in the country typically diagnosed at an advanced stage, the disease has

Today, we're joined by Ivan Kairatov, a leading biopharma expert whose recent work has uncovered a startling new mechanism used by SARS-CoV-2. His team's research reveals how the virus doesn't just evade the immune system but actively commandeers the host's cellular machinery in a way never before

The delicate balance of pharmaceutical innovation often hinges on a single set of clinical data, and for the Belgian biotech firm Galapagos, the recent trial results for its experimental drug GLPG3667 have created a narrative of both triumph and tribulation. This TYK2 inhibitor, designed to quell

In an industry where the path from laboratory concept to patient bedside is often decades long and costs billions, the traditional, siloed approach to research and development is proving increasingly insufficient for tackling today's complex medical challenges. A new paradigm of "open innovation"

A significant and persistent gap in stroke risk between Black and White adults in the United States has long challenged the medical community, but a newly validated assessment tool offers a promising new direction for closing this divide through personalized, actionable health insights. A

A state-of-the-art biologic drug, meticulously designed to fight a specific disease and carrying a price tag that can exceed several hundred thousand dollars, inexplicably fails in a patient who seemed a perfect candidate for the treatment. This frustrating scenario, long a puzzle for clinicians,

The routine procedure of drawing blood remains one of the most common yet consistently invasive practices in modern medicine, a necessary discomfort for millions seeking crucial health insights. But a new frontier in diagnostics is emerging, one that promises to replace the needle with a simple,

With deep expertise in biopharmaceutical innovation and a sharp focus on oncology, Ivan Kairatov has been at the forefront of translating complex molecular discoveries into potential therapeutic strategies. Today, he joins us to discuss a groundbreaking study that shines a new light on one of

The quiet revolution happening in primary care clinics across the globe is driven by an artificial intelligence that promises to solve systemic pressures but is simultaneously creating a significant, unaddressed patient safety crisis. This paradox lies at the heart of AI's rapid adoption into the